Mammoth Biosciences just raised $45 million in Series B funding for their Crispr diagnostics, and they already have several partnerships in the works.
Mammoth Biosciences Raises $45 Million For Crispr Diagnostics—And Its Tech Is Already Being Used Against Coronavirus
